Target intelligence / Profile preview

Candida species cellular structures

Molecular classification
Cell wall, Cell membrane, Organelle, Cytoskeleton
01

Overview

Candida species cellular structures refer to the collective physical and biochemical components of fungi within the Candida genus, primarily focusing on the cell wall and cell membrane. The cell wall is a dynamic structure composed of chitin, beta-glucans, and mannoproteins, which provides essential osmotic protection and serves as a scaffold for surface proteins involved in host adhesion (NIH, 2022). The cell membrane is characterized by the presence of ergosterol, a sterol functionally analogous to cholesterol in humans but structurally distinct, making it a primary target for selective toxicity (StatPearls, 2023). Therapeutic agents like echinocandins target the synthesis of cell wall glucans, while azoles and polyenes target ergosterol synthesis and membrane integrity, respectively (PubMed, 2021). These structures are critical for the transition of Candida from commensal yeast to pathogenic hyphal forms during infection. Because this entry describes a broad category of structural components rather than a single protein or receptor, it is considered a general descriptive term for multiple distinct drug targets (CDC, 2023). Understanding these structures is vital for developing treatments against invasive candidiasis and addressing the rising challenge of antifungal resistance.

Other names
Candida cell wallCandida cell membraneFungal cellular componentsCandida ultrastructure
02

Mechanism of action

Inhibition of 1,3-beta-glucan synthesis in the cell wall, inhibition of lanosterol 14-alpha-demethylase to prevent ergosterol synthesis, direct binding to ergosterol to create membrane pores, and inhibition of squalene epoxidase.

03

Biological functions

Structural integrityOsmotic regulationAdhesionPathogenesisNutrient transportMorphological transition
04

Disease associations

InfectionCandidiasisCandidemiaVaginal yeast infectionOral thrushInvasive fungal infection
05

Safety considerations

Nephrotoxicity (associated with Polyenes)Hepatotoxicity (associated with Azoles)Infusion-related reactionsDrug-drug interactions via Cytochrome P450 inhibitionEmerging multidrug resistance in species like Candida auris
06

Interacting drugs

Fluconazole

9 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG)Candida mannan antigenAnti-mannan antibodiesCandida albicans germ tube specific antibody (CAGTA)T2Candida panel

Beyond the preview

Go deeper on Candida species cellular structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida species cellular structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call